All In Biotech

Drug Trial Radar · NCT05255991

Multinational Study of Efficacy and Safety of Inhaled Treprostinil in Subjects With Idiopathic Pulmonary Fibrosis

A Randomized, Double-blind, Placebo-controlled, Multinational, Phase 3 Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Idiopathic Pulmonary Fibrosis (TETON-2)

Last checked: Nov 19, 2026Latest source record: Oct 15, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingPhase 3. Randomized with 597 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

597

Actual

Start

Sep 12, 2022

Primary completion

Jun 30, 2025

Study completion Jun 30, 2025

Sponsor

Lead sponsor
United TherapeuticsIndustry
Sponsor type
Industry
First posted
Feb 25, 2022

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 40 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Study RIN-PF-303 is a multinational study designed to evaluate the superiority of inhaled treprostinil against placebo for the change in absolute forced vital capacity (FVC) from baseline to Week 52.

Conditions

  • Idiopathic Pulmonary Fibrosis
  • Interstitial Lung Disease

Interventions

  • PlaceboDrug

    Placebo administered QID

  • Inhaled TreprostinilDrug

    Inhaled treprostinil (6 mcg/breath) administered QID

  • Treprostinil Ultrasonic NebulizerDevice

    Treprostinil ultrasonic nebulizer which emits a dose of approximately 6 mcg per breath.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Change in Absolute FVC From Baseline to Week 52Time frame: Baseline to Week 52

Locations

108 sites in 16 countries. Site status is shown where the registry gives one.

  • CINME S.A. - Centro de Investigaciones Metabolicas

    Ciudad Autonoma de Buenos Aires, Buenos Aires, Argentina

  • Centro Medico Dra. De Salvo

    Ciudad Autonoma de Buenos Aires, Buenos Aires, Argentina

  • Instituto Ave Pulmo - Fundación enfisema

    Mar del Plata, Buenos Aires, Argentina

  • Sanatorio Allende S.A.

    Córdoba, Córdoba Province, Argentina

  • Instituto Médico Río Cuarto

    Río Cuarto, Córdoba Province, Argentina

  • Centro Médico INSARES

    Mendoza, Mendoza Province, Argentina

  • Sanatorio Parque - Consultorios Externos

    Rosario, Santa Fe Province, Argentina

  • Centro Integral de Medicina Respiratoria

    San Miguel de Tucumán, Tucumán Province, Argentina

  • Investigaciones en Patologías Respiratorias

    San Miguel de Tucumán, Tucumán Province, Argentina

  • Royal Prince Alfred Hospital, Missenden Road

    Camperdown, New South Wales, Australia

  • Macquarie University

    Macquarie Park, New South Wales, Australia

  • Westmead Hospital, Corner of Hawkesbury and Darcy Road

    Westmead, New South Wales, Australia

  • Cairns Hospital

    Cairns, Queensland, Australia

  • Lung Research Qld

    Chermside, Queensland, Australia

  • Prince Charles Hospital

    Chermside, Queensland, Australia

  • Mater Misericordiae Ltd

    South Brisbane, Queensland, Australia

  • Respiratory Clinical Trials Pty Ltd

    Kent Town, South Australia, Australia

  • Alfred Health

    Melbourne, Victoria, Australia

  • Austin Health

    Melbourne, Victoria, Australia

  • Institute for Respiratory Health - Midland

    Nedlands, Western Australia, Australia

  • Institute for Respiratory Health - Nedlands

    Nedlands, Western Australia, Australia

  • AZORG vzw

    Aalst, Belgium

  • Ziekenhuis Aan de Stroom

    Antwerp, Belgium

  • Cliniques Universitaires Saint-Luc

    Brussels, Belgium

  • UZ Leuven

    Leuven, Belgium

  • CHR de la Citadelle

    Liège, Belgium

  • CHU de Liège

    Liège, Belgium

  • Hôpital Erasme

    Anderlecht, Brussels Capital, Belgium

  • CHU UCL Namur asbl - Site Godinne

    Yvoir, Namur, Belgium

  • Centro de Investigacion del Maule SpA

    Talca, Maule Region, Chile

  • Instituto Nacional Torax

    Santiago, Santiago Metropolitan, Chile

  • Fundación Médica San Cristobal

    Santiago, Santiago Metropolitan, Chile

  • Oncocentro APYS

    Viña del Mar, Valparaiso, Chile

  • Aarhus University Hospital - Department of Respiratory Diseases and Allergy, Research Unit

    Aarhus N, Denmark

  • Gentofte Hospital - Lungemedicinsk forskning

    Hellerup, Denmark

  • Odense University Hospital - Department of Respiratory Medicine J.

    Odense C, Denmark

  • CHU Amiens Picardie Site Sud - Service de Pneumologie

    Amiens, France

  • Hopital Cote de Nacre

    Caen, France

  • Groupement Hospitalier EST, Service de Pneumologie

    Lyon, France

  • APHM-Hôpital Nord

    Marseille, France

Showing 40 of 108 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.